![Ajay Ahuja](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 1 M $ al 31/07/2026
Ajay Ahuja is Chief Medical Officer at MannKind Corp.
since 2025.
Formerly, Dr. Ahuja was Director-Business Development at Tepha, Inc. Education includes an MBA from Harvard Business School and a doctorate from Washington University School of Medicine.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
MANNKIND CORPORATION 0,1 % | 23/03/2026 | 318.200 ( 0,1 % ) | 1 M $ | 31/07/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| MANNKIND CORPORATION | Director Técnico/Científico/I+D | 29/09/2025 |
| Empresas | Cargo | Fin |
|---|---|---|
Tepha, Inc.
 Tepha, Inc. Medical SpecialtiesHealth Technology Develops and commercializes medical devices and biomaterial technology | Corporate Officer/Principal | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 4 |
|---|---|
MannKind Corp.
 MannKind Corp. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes therapeutic products | Health Technology |
Tepha, Inc.
Tepha, Inc. Medical SpecialtiesHealth Technology Develops and commercializes medical devices and biomaterial technology | Health Technology |
Harvard Business School
 Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Washington University School of Medicine
 Washington University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
